Dr. Prenek Lilla
PROactively TACkling CDK4/6 therapy resistance | Nature Cancer
Small molecule CDK4/6 inhibitors inhibit cell cycle progression by... | Download Scientific Diagram
Overview of CDK4/6 and MAPK inhibitors. (a) FDA approved small-molecule... | Download Scientific Diagram
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding | PNAS
Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs - ScienceDirect
Dr. Prenek Lilla
Inhibition of G1/S cyclin-dependent kinases by CDK4/6 inhibitors. A The... | Download Scientific Diagram
The Use of Post-attachment Inhibitors for HIV Treatment
Mechanisms of therapeutic CDK4/6 inhibition in breast cancer - ScienceDirect
Immunomodulatory effects of CDK4/6 inhibition. (A) CDK4/6 inhibition... | Download Scientific Diagram
Uptake és efflux transzporterekkel kölcsönható vegyületek azonosítása robotizált platformon
dc_2020_22
Mechanism of action of CTLA-4 checkpoint inhibitor. CTLA-4 and CD28 are... | Download Scientific Diagram
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
Treating cancer with selective CDK4/6 inhibitors | Nature Reviews Clinical Oncology
Mechanisms of the CDK4/6 inhibitor palbociclib (PD 0332991) and its future application in cancer treatment (Review)
Co-inhibitory signals. (A) CTLA-4 signal may inhibit T cells through... | Download Scientific Diagram
Discovery of novel CDK inhibitors via scaffold hopping from CAN508 - ScienceDirect
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding | PNAS
Senescence as a therapeutically relevant response to CDK4/6 inhibitors | Oncogene
Myeloid immune-checkpoint inhibition enters the clinical stage | Nature Reviews Clinical Oncology
dc_2020_22
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2 | Nature Communications
